
|Articles|August 15, 2008
OTC MEVACOR GETS THUMBS DOWN AGAIN-January 2008
Merck & Co Inc's third bid
Advertisement
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Advancing Treatment After CDK4/6 Inhibitor Progression in HR+/HER2– Breast Cancer
2
FDA Approves Etuvetidigene Autotemcel, First Gene Therapy for Wiskott-Aldrich Syndrome
3
Experts Weigh In on GLP-1 Agonist Use in Pediatric Patients with Obesity
4
Automation and Standardization Take Center Stage in Health System’s Centralized IV Compounding Strategy
5


















































































































































































































